Phase II clinical research design in cardiology: learning the right lessons too well: observations and recommendations from the Cardiovascular Cell Therapy Research Network (CCTRN)

Hare, Joshua M.Bolli, RobertoCooke, John P.Gordon, David J.Henry, Timothy D.Perin, Emerson C.March, Keith L.Murphy, Michael P.Pepine, Carl J.Simari, Robert D.Skarlatos, Sonia I.Traverse, Jay H.Willerson, James T.Szady, Anita D.Taylor, Doris A.Vojvodic, Rachel W.Yang, Phillip C.Moyé, Lemuel A.Cardiovascular Cell Therapy Research Network (CCTRN)2025-05-122025-05-122013Hare JM, Bolli R, Cooke JP, et al. Phase II clinical research design in cardiology: learning the right lessons too well: observations and recommendations from the Cardiovascular Cell Therapy Research Network (CCTRN). Circulation. 2013;127(15):1630-1635. doi:10.1161/CIRCULATIONAHA.112.000779https://hdl.handle.net/1805/47952en-USPublisher PolicyCardiovascular agentsCardiovascular diseasesBiomarkersHeart function testsPhase II clinical research design in cardiology: learning the right lessons too well: observations and recommendations from the Cardiovascular Cell Therapy Research Network (CCTRN)Article